Aravive, Inc.
ARAVDelisted Jan 29, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513818
Aravive, Inc. was delisted on Jan 29, 2024; its insiders filed their last Form 4 on Apr 11, 2023; 30 institutions reported holding it in 13F filings for Q4 2023, worth $825.5K in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Aravive, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 37 | 36 | −1 |
| Shares | 5.24M | 5.54M | +303.5K (+5.8%) |
| Value | $10.1M | $5.47M | −$4.63M (−45.8%) |
New holders (4)
Institutions that held Aravive, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Assenagon Asset Management S.A. | 46,027 | $45.0K | 0.00% |
| Citadel Advisors LLC | 13,031 | $13.0K | 0.00% |
| Goldman Sachs Group Inc | 11,248 | $11.0K | 0.00% |
| FMR LLC | 2,500 | $2.00K | 0.00% |
Sold out (5)
Institutions that held Aravive, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Susquehanna International Group, LLP | 55,865 | $108.0K |
| Verition Fund Management LLC | 25,000 | $48.0K |
| Geneos Wealth Management Inc. | 12,810 | $24.0K |
| Citigroup Inc | 1,479 | $3.00K |
| Federated Hermes, Inc. | 441 | $1.00K |